KKR gains as investors digest fresh filings and renewed analyst optimism

KKR & Co. Inc. (KKR) is up 3.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a renewed confidence setup: recent SEC disclosures around KKR-linked positioning and insider activity, plus a notable sell-side price-target increase, may have helped spark incremental buying after a volatile stretch for alternative asset managers. Broader risk-on sentiment in financials can amplify these single-stock catalysts.

Details:

A recent SEC Schedule 13D/A disclosed KKR-affiliated entities’ sizable economic exposure to Henry Schein, including shares and swap-related rights to acquire additional notional exposure.

Recent SEC Form 4 disclosures have highlighted insider activity tied to KKR, which some investors interpret as a confidence signal when shares are under pressure.

A major bank analyst recently raised KKR’s price target while keeping a constructive stance, citing improving conditions for alternative managers.

Investors also continue to weigh KKR’s most recent quarterly update and commentary on fee trends and outlook, which can influence sentiment around earnings durability.

Sources:

U.S. Securities and Exchange Commission, KKR Investor Relations, TipRanks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$KKR Insider Trading Activity

$KKR insiders have traded $KKR stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KKR stock by insiders over the last 6 months:

SCOTT C NUTTALL (Co-Chief Executive Officer) has made 3 purchases buying 125,000 shares for an estimated $12,833,087 and 0 sales.
JOSEPH Y BAE (Co-Chief Executive Officer) has made 4 purchases buying 125,000 shares for an estimated $12,773,530 and 0 sales.
TIMOTHY R BARAKETT has made 2 purchases buying 100,000 shares for an estimated $9,970,000 and 0 sales.
MATT COHLER purchased 43,872 shares for an estimated $4,514,428

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$KKR Hedge Fund Activity

We have seen 630 institutional investors add shares of $KKR stock to their portfolio, and 719 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 10,010,829 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $1,276,180,480
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 5,879,512 shares (+7554.7%) to their portfolio in Q4 2025, for an estimated $749,520,189
CAPITAL INTERNATIONAL INVESTORS added 5,832,705 shares (+18.6%) to their portfolio in Q4 2025, for an estimated $743,553,233
CAPITAL WORLD INVESTORS removed 4,130,462 shares (-38.6%) from their portfolio in Q4 2025, for an estimated $526,551,295
STRIVE ASSET MANAGEMENT, LLC added 4,123,951 shares (+inf%) to their portfolio in Q3 2025, for an estimated $535,907,432
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,163,915 shares (-60.4%) from their portfolio in Q4 2025, for an estimated $403,335,884
WELLINGTON MANAGEMENT GROUP LLP added 2,949,378 shares (+12.3%) to their portfolio in Q4 2025, for an estimated $375,986,707

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$KKR Government Contracts

We have seen $91,496 of award payments to $KKR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

BIOSEARCH TECHNOLOGIES - PRIMERS AND PROBES: $51,128

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$KKR Congressional Stock Trading

Members of Congress have traded $KKR stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $KKR stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 11/19.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 10/17 and 1 sale worth up to $15,000 on 11/07.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$KKR Analyst Ratings

Wall Street analysts have issued reports on $KKR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

TD Cowen issued a "Buy" rating on 11/10/2025
Morgan Stanley issued a "Overweight" rating on 10/21/2025
Oppenheimer issued a "Outperform" rating on 10/14/2025

To track analyst ratings and price targets for $KKR, check out Quiver Quantitative's $KKR forecast page.

$KKR Price Targets

Multiple analysts have issued price targets for $KKR recently. We have seen 8 analysts offer price targets for $KKR in the last 6 months, with a median target of $142.5.

Here are some recent targets:

Benjamin Budish from Barclays set a target price of $127.0 on 03/02/2026
Bart Dziarski from RBC Capital set a target price of $137.0 on 02/24/2026
Michael Brown from UBS set a target price of $125.0 on 02/20/2026
Chris Kotowski from Oppenheimer set a target price of $187.0 on 02/06/2026
Bill Katz from TD Cowen set a target price of $131.0 on 01/14/2026
Michael Cyprys from Morgan Stanley set a target price of $166.0 on 10/21/2025
Christopher Allen from Citigroup set a target price of $150.0 on 10/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.